You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interleukin-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Periodontitis, Gingivitis, Periodontal Health Trial in Aydin (Periodontal clinical measurements, GCF and saliva sampling)

Completed
  • Periodontitis
  • +2 more
  • Periodontal clinical measurements, GCF and saliva sampling
  • Aydın, Turkey
    Aydın Adnan Menderes University
Oct 26, 2023

Hyperinsulinemia, PreDiabetes Trial in Basel (Anakinra, Placebo)

Not yet recruiting
  • Hyperinsulinemia
  • PreDiabetes
  • Basel, Switzerland
    University Hospital Basel
May 2, 2023

Interleukin-1ß Gene Polymorphism May Increase Risk of Developing

Completed
  • Lumbar Disc Degeneration
  • +2 more
    • Istanbul, Turkey
      Yeditepe University
    Oct 31, 2022

    Beta Endorphins,Interleukin 1 and Interleukin 38 in Covid

    Recruiting
    • Covid Patients
    • βeta endorphins, interleukin 6 and interleukin 38
    • Assiut, Egypt
      Assiut university
    Jan 22, 2022

    COPD Exacerbation Acute, Ascaris Lumbricoides Infection, Chronic Pulmonary Aspergillosis Trial (Interleukin-1B, Interleukin-4,

    Not yet recruiting
    • COPD Exacerbation Acute
    • +2 more
    • Interleukin-1B
    • +4 more
    • (no location specified)
    Mar 23, 2023

    GCF Galectin-3 and Interleukin-1beta Levels in Periodontitis.

    Completed
    • Periodontitis
    • Periodontal Inflammation
    • Periodontal clinical measurements and gingival crevicular fluid sampling
    • Aydın, Turkey
      Adnan Menderes University, Faculty of Dentistry, Department of P
    Jul 4, 2022

    Allergic Contact Dermatitis Trial (Anakinra, Sodium Chloride 9mg/ml Injection)

    Not yet recruiting
    • Allergic Contact Dermatitis
    • (no location specified)
    Aug 9, 2022

    Vitamin D Receptor, Interleukin-1A and Interleukin-1B Gene

    Completed
    • Periodontitis
    • Polymorphism, Restriction Fragment Length
      • İstanbul, Maltepe, Turkey
      • +1 more
      Nov 30, 2021

      Heart Failure Trial in Charlottesville, Richmond (Anakinra, Placebo)

      Recruiting
      • Heart Failure
      • Charlottesville, Virginia
      • +1 more
      May 31, 2022

      Netosis During COVID-19, Under Treatment With

      Active, not recruiting
      • Covid19
        • Paris, France
        • +1 more
        Mar 30, 2022

        Drug Resistant Epilepsy Trial in Medan (Cholecalciferol, )

        Not yet recruiting
        • Drug Resistant Epilepsy
        • Medan, North Sumatra, Indonesia
          Faculty of Medicine Universitas Sumatera Utara
        Sep 21, 2023

        Cardiac Sarcoidosis Trial in Ann Arbor, Richmond (Anakinra)

        Recruiting
        • Cardiac Sarcoidosis
        • Ann Arbor, Michigan
        • +1 more
        Nov 8, 2021

        Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

        Recruiting
        • Acute Myeloid Leukemia
        • +4 more
        • Recombinant Interleukin-7
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 26, 2023

        Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

        Not yet recruiting
        • Esophageal Cancer
        • +3 more
        • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
        • Edegem, Belgium
          Antwerp University Hospital
        Jul 19, 2023

        Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)

        Completed
        • Intracerebral Haemorrhage
        • IL-1Ra Kineret®
        • IL-1Ra Placebo
        • Manchester, North West, United Kingdom
          Salford Royal NHS Foundation Trust
        Oct 4, 2021

        Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

        Active, not recruiting
        Has Results
        • Kidney Cancer
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Jun 21, 2022

        Early Disease Onset Trial (Puva (psoralin and uva ))

        Not yet recruiting
        • Early Disease Onset
        • Puva (psoralin and uva )
        • (no location specified)
        Sep 27, 2023

        Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

        Not yet recruiting
        • Pericarditis
        • IL1RA Antibody Assay
        • suPAR Testing
        • Homburg, Germany
        • +8 more
        Jun 22, 2023

        Keloid, Stem Cell Trial in Jakarta Pusat (umbilical cord-derived mesenchymal stem cells (UC-MSC), umbilical cord-derived

        Completed
        • Keloid
        • Stem Cell
        • umbilical cord-derived mesenchymal stem cells (UC-MSC)
        • +2 more
        • Jakarta Pusat, DKI Jakarta, Indonesia
          RSPAD Gatot Soebroto
        Jul 1, 2023

        Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

        Not yet recruiting
        • Triple Negative Breast Cancer
        • Proleukin 1.3 MG Injection
        • (no location specified)
        Apr 6, 2023

        Periodontitis Trial in Rize (biochemical analysis)

        Completed
        • Periodontitis
        • biochemical analysis
        • Rize, Turkey
          Recep Tayyip Erdogan University
        Oct 18, 2023

        Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

        Active, not recruiting
        • Malignant Neoplasm
        • aldesleukin
        • +7 more
        • Los Angeles, California
          University of California at Los Angeles (UCLA )
        Dec 1, 2022

        Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

        Not yet recruiting
        • Clinical Stage IV Cutaneous Melanoma AJCC v8
        • +3 more
        • Biospecimen Collection
        • +8 more
        • Kansas City, Kansas
          University of Kansas Cancer Center
        Nov 27, 2023

        HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

        Recruiting
        • HIV-1-infection
        • INO-6160, 2 mg
        • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
        • New York, New York
        • +2 more
        Apr 13, 2023

        Melanoma (Skin), Melanoma in Situ Trial in Halifax (Aldesleukin, Saline)

        Suspended
        • Melanoma (Skin)
        • Melanoma in Situ
        • Aldesleukin
        • Saline
        • Halifax, Nova Scotia, Canada
          Queen Elizabeth II Health Sciences Centre
        Jul 18, 2022